BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

510 related articles for article (PubMed ID: 11795443)

  • 1. Beyond tamoxifen new endpoints for breast cancer chemoprevention, new drugs for breast cancer prevention.
    Fabian CJ; Kimler BF
    Ann N Y Acad Sci; 2001 Dec; 952():44-59. PubMed ID: 11795443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention for high-risk women: tamoxifen and beyond.
    Fabian CJ; Kimler BF
    Breast J; 2001; 7(5):311-20. PubMed ID: 11906441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer chemoprevention: beyond tamoxifen.
    Fabian CJ
    Breast Cancer Res; 2001; 3(2):99-103. PubMed ID: 11250754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preventive therapy for breast cancer: a consensus statement.
    Cuzick J; DeCensi A; Arun B; Brown PH; Castiglione M; Dunn B; Forbes JF; Glaus A; Howell A; von Minckwitz G; Vogel V; Zwierzina H
    Lancet Oncol; 2011 May; 12(5):496-503. PubMed ID: 21441069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Breakthrough in breast cancer chemoprevention].
    Kahán Z; Thurzó L
    Orv Hetil; 2003 Mar; 144(13):597-603. PubMed ID: 12728784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoprevention of breast cancer: implications for postmenopausal women.
    Fabian CJ; Kimler BF
    Drugs Aging; 2002; 19(1):43-78. PubMed ID: 11929326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention of breast cancer.
    Zelnak AB; O'Regan RM
    Curr Probl Cancer; 2004; 28(4):201-17. PubMed ID: 15318323
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal women.
    Decensi A; Robertson C; Guerrieri-Gonzaga A; Serrano D; Cazzaniga M; Mora S; Gulisano M; Johansson H; Galimberti V; Cassano E; Moroni SM; Formelli F; Lien EA; Pelosi G; Johnson KA; Bonanni B
    J Clin Oncol; 2009 Aug; 27(23):3749-56. PubMed ID: 19597031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of breast cancer: current state of the science and future opportunities.
    Uray IP; Brown PH
    Expert Opin Investig Drugs; 2006 Dec; 15(12):1583-600. PubMed ID: 17107283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SERMs in chemoprevention of breast cancer.
    Gasco M; Argusti A; Bonanni B; Decensi A
    Eur J Cancer; 2005 Sep; 41(13):1980-9. PubMed ID: 15964182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and evolution of therapies targeted to the estrogen receptor for the treatment and prevention of breast cancer.
    Jordan VC; Brodie AM
    Steroids; 2007 Jan; 72(1):7-25. PubMed ID: 17169390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast Cancer Chemoprevention among High-risk Women and those with Ductal Carcinoma In Situ.
    Reimers LL; Sivasubramanian PS; Hershman D; Terry MB; Greenlee H; Campbell J; Kalinsky K; Maurer M; Jayasena R; Sandoval R; Alvarez M; Crew KD
    Breast J; 2015; 21(4):377-86. PubMed ID: 25879521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective estrogen receptor modulators (SERMs) and retinoids in breast cancer chemoprevention.
    Zujewski J
    Environ Mol Mutagen; 2002; 39(2-3):264-70. PubMed ID: 11921197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoprevention of breast cancer.
    Castrellon AB; Glück S
    Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyto-oestrogens and breast cancer chemoprevention.
    Limer JL; Speirs V
    Breast Cancer Res; 2004; 6(3):119-27. PubMed ID: 15084232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.
    Uray IP; Brown PH
    Recent Results Cancer Res; 2011; 188():147-62. PubMed ID: 21253797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective estrogen receptor modulation: the search for an ideal hormonal therapy for breast cancer.
    Dhingra K
    Cancer Invest; 2001; 19(6):649-59. PubMed ID: 11486708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemoprevention of breast cancer in the older patient.
    Minton SE
    Hematol Oncol Clin North Am; 2000 Feb; 14(1):113-30. PubMed ID: 10680075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hormones in cancer prevention.
    Vogel VG
    Am Soc Clin Oncol Educ Book; 2014; ():34-40. PubMed ID: 24857058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.